From: Prevalence of human anelloviruses in Romanian healthy subjects and patients with common pathologies
Variable | History of HAV infection (n = 390) | Surgical proceduresa (n = 777) | Undergone dialysis/transfusions (n = 190) | |||
---|---|---|---|---|---|---|
TTV DNA positive | 304 (77.9%)* OR = 1.8 (95% CI 1.4–2.4) | 591 (76%)* OR = 1.8 (95% CI 1.5–2.3) | 169 (88.9%)* OR = 4.1 (95% CI 2.6–6.6) | |||
Men | Women | Men | Women | Men | Women | |
152/189 (80.4%)* OR = 2.1 (95% CI 1.4–3.1) | 152/201 (75.6%)** | 112/130 (86.1%)* OR = 3.2 (95% CI 1.9–5.3) | 475/647 (73.4%)* OR = 2 (95% CI 1.6–2.6) | 69/79 (87.3%)* OR = 3.3 (95% CI 1.7–6.6) | 100/111 (90.1%)* OR = 4.9 (95% CI 2.6–9.3) | |
TTMDV DNA positive | 260 (66.7%)* OR = 1.9 (95% CI 1.5–2.4) | 507 (65.2%)* OR = 2 (95% CI 1.7–2.5) | 149 (78.4%)* OR = 3.4 (95% CI 2.3–4.8) | |||
Men | Women | Men | Women | Men | Women | |
128/189 (67.7%)* OR = 2.4 (95% CI 1.7–3.3) | 132/201 (65.6%) ** | 92/130 (70.7%)* OR = 2.6 (95% CI 1.7–4) | 414/647 (64%)* OR = 2 (95% CI 1.5–2.5) | 61/79 (77.2%)* OR = 3.6 (95% CI 2.1–6.2) | 88/111 (79.2%)* OR = 3.2 (95% CI 2–5.1) | |
TTMV DNA positive | 220 (56.4%)* OR = 2.3 (95% CI 1.8–2.8) | 383 (47.8%)* OR = 1.8 (95% CI 1.5–2.2) | 130 (68.4%)* OR = 3.6 (95% CI 2.6–5) | |||
Men | Women | Men | Women | Men | Women | |
117 / 189 (61.9%)* OR = 3.5 (95% CI 2.5–4.8) | 103/201 (51.2%)** | 83/130 (63.8%)* OR = 3.5 (95% CI 2.3–5.1) | 300/647 (46.3%)* OR = 1.6 (95% CI 1.2–2) | 61/79 (77.2%)* OR = 6.8 (95% CI 3.7–11.1) | 69/111 (62.1%)* OR = 2.5 (95% CI 1.7–3.8) |